The catalog says SLU-PP-322, while the published ERR agonist is SLU-PP-332—a mismatch that must be resolved.
SLU-PP-322 is presented here as a catalog identifier, but the primary literature located for the estrogen-related-receptor chemical probe uses the name SLU-PP-332. That one-digit difference is material, not cosmetic.
What the published compound does
SLU-PP-332 is a synthetic small molecule—not a peptide—reported as a pan-agonist of ERR alpha, beta, and gamma, with highest potency at ERR alpha. Cell and mouse studies examined mitochondrial respiration, oxidative muscle-fiber programs, and exercise-related transcription.
What cannot be assigned to this listing
The SLU-PP-332 mechanism must not be attributed to a vial labeled SLU-PP-322 unless the supplier confirms that 322 is a typographical error and provides matching structure, CAS or internal identifier, molecular formula, mass, chromatogram, and identity spectrum. This is a pre-launch identity blocker.
Primary source for SLU-PP-332
Research-use notice: For laboratory research use only. Not for human or veterinary use, ingestion, injection, therapeutic, diagnostic, or clinical use. This educational material summarizes research context; it is not medical advice and does not establish safety, efficacy, identity, purity, or suitability for any use.